Explanatory Note
This Amendment No. 5 (the “Amendment”) amends the statement on Schedule 13D originally filed by the Reporting Person on May 17, 2017, as amended by Amendment No. 1 to the Schedule 13D filed on March 8, 2018, Amendment No. 2 to the Schedule 13D filed on March 1, 2019, Amendment No. 3 to the Schedule 13D filed on February 28, 2020 and Amendment No. 4 to the Schedule 13D filed on April 23, 2020 (the “Schedule 13D”). Capitalized terms used but not defined in this Amendment shall have the meanings ascribed to such terms in the Schedule 13D. Except as otherwise provided herein, each Item of the Schedule 13D remains unchanged. This Amendment is being filed to report the receipt by the Reporting Person on March 15, 2021 of a compensatory equity incentive award by the Issuer, as described below.
Item 3. | Source and Amount of Funds or Other Consideration. |
The information set forth in Item 4, as amended, is incorporated by reference herein.
Item 4. | Purpose of the Transaction. |
Item 4 is hereby amended and supplemented as follows:
On February 23, 2021, the Reporting Person, who serves as the Chief Executive Officer of the Issuer, earned 18,181 additional restricted shares of Class A Common Stock in connection with a compensatory equity incentive award under the 2016 Plan previously granted to the Reporting Person on April 17, 2020 in the initial amount of 227,273 performance-based restricted shares of Class A Common Stock. The Reporting Person earned the 18,181 additional shares of Class A Common Stock upon the certification by the Compensation Committee of the Board of achievement above target by the Issuer of specified performance goals related to such performance award in accordance with the terms of such award.
On March 15, 2021, the Reporting Person received a compensatory equity incentive award under the 2016 Plan approved by the Board in the aggregate amount of 466,644 shares, consisting of 233,322 time-based restricted shares of Class A Common Stock awarded pursuant to the Issuer’s applicable form of Restricted Stock Agreement for executives and 233,322 performance-based restricted shares of Class A Common Stock awarded pursuant to the Issuer’s applicable form of Performance-Based Restricted Stock Agreement for executives.
Item 5. | Interest in Securities of the Issuer. |
Items 5(a), (b) and (c) are hereby amended in their entirety as follows:
(a) | As of March 17, 2021, the Reporting Person beneficially owned 2,590,462 shares of the Class A Common Stock, consisting of (i) 1,138,482 restricted shares of Class A Common Stock which are subject to vesting, (ii) 889,183 shares of Class A Common Stock which the Reporting Person either may acquire upon the exercise of vested stock options or will be able to acquire upon the exercise of stock options vesting as of or within 60 days after such date and (iii) 562,797 unrestricted shares of Class A Common Stock. As of such date, the 2,590,462 shares of Class A Common Stock beneficially owned by the Reporting Person represented approximately 18.6% of the shares of Class A Common Stock.(1) |
(b) | As of March 17, 2021, the Reporting Person has: |
| (i) | sole power to vote or direct the vote of 2,590,462 shares of Class A Common Stock; |
| (ii) | shared power to vote or direct the vote of -0- shares of Class A Common Stock; |
(1) | Based on 13,029,259 shares of Class A Common Stock outstanding as of March 17, 2021, as provided by the Issuer. |
3 of 6